Harvard Bioscience
HBIO
HBIO
74 hedge funds and large institutions have $80.6M invested in Harvard Bioscience in 2014 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 24 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
13% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 24
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
74
Holding in Top 10
1
Calls
$167K
Puts
$10K
Top Buyers
| 1 | +$3.76M | |
| 2 | +$2.8M | |
| 3 | +$1.64M | |
| 4 |
GPC
Glacier Peak Capital
Bellevue,
Washington
|
+$925K |
| 5 |
Renaissance Technologies
New York
|
+$709K |
Top Sellers
| 1 | -$3.09M | |
| 2 | -$2.97M | |
| 3 | -$2.34M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.44M |
| 5 |
SO
STRS Ohio
Columbus,
Ohio
|
-$658K |